Sort
23,748 grants matching “melanoma”
Salmonella as a vector for delivery of oncolytic viruses to hepatocellular carcinoma
$402,147Neil S Forbes · University Of Massachusetts Amherst · R21 · FY2024 · CA
Palliative Care: Maximizing Patient Preference and Cost Savings
$402,137Donald H Taylor · Duke University · R01 · FY2009 · HS
Cancer and Leukemia Group B - The Ohio State University
$402,122Ohio State University · U10 · FY2003 · CA
PROTEAN-CR: Proteomics Toolkit for Ensemble Analysis in Cancer Research
$402,077Lydia E. Kavraki · Rice University · U01 · FY2021 · CA
Bioeffects of Gas Body Activation in Medical Ultrasound
$401,993University Of Michigan At Ann Arbor · R01 · FY2001 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$401,968Melanie R Rutkowski · University Of Virginia · R01 · FY2021 · CA
ALGORITHMS FOR PIGMENTED LESION SCREENING AND DETECTION
$401,943Stoecker &Associates · R44 · FY2000 · CA
The role of genetic susceptibility in melanoma development
$401,931Meenhard Herlyn · Wistar Institute · R01 · FY2015 · CA
Synergistic Targeting of the MAP Kinase Pathway in Melanoma
$401,919Ronen Marmorstein · Wistar Institute · P01 · FY2014 · CA
Endothelial Transdifferentiation of Invasive Tumor Cells
$401,734Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R37 · FY2007 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$401,557University Of Pennsylvania · U10 · FY2000 · CA
The genomic landscape and evolution of cutaneous squamous cell carcinoma
$401,527Alan Hunter Shain · University Of California, San Francisco · R01 · FY2023 · CA
Experimental Transformation of Human Melanocytes in Vivo
$401,520Wistar Institute · R01 · FY2005 · CA
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$401,513Edgar G. Engleman · Stanford University · U54 · FY2017 · CA
Nuclear receptors: action, functions, and roles in disease
$401,496Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Engineered Ensemble Nanoimmunotherapies for Cancer
$401,491Rohan Fernandes · George Washington University · R37 · FY2022 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2016 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2015 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$401,430Craig Lee Slingluff · University Of Virginia · U01 · FY2013 · CA
Molecular Epidemiology of Melanoma
$401,292Peter A Kanetsky · University Of Pennsylvania · R01 · FY2006 · CA
Preclinical Development of PEG-TNF
$401,250Phoenix Pharmacologics, Inc. · R44 · FY2004 · CA
HIV, HERV-K and Human Cancer
$401,250Marie-Louise Hammarskjold · University Of Virginia · R01 · FY2017 · CA
Core 1: Biospecimen and Data Management Core
$401,189John B Sunwoo · Stanford University · U54 · FY2019 · CA
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$401,153Yi Lin · Mayo Clinic Rochester · R01 · FY2020 · CA